Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
393.1 USD | -0.27% | -1.13% | -3.39% |
Apr. 17 | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
Apr. 17 | Guggenheim Adjusts Vertex Pharmaceuticals' Price Target to $450 From $445 | MT |
Filters
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated